RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 427.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 410.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2,205.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -1,494.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1,328.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -5,838.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1,382.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 889.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -50,010.00 |
| Mar 31, 2023 | -16,806.00 |
| Dec 31, 2022 | 4,839.00 |
| Sep 30, 2022 | 5,373.00 |
| Jun 30, 2022 | -162.00 |
| Mar 31, 2022 | 2,758.00 |
| Dec 31, 2021 | -834.00 |
| Sep 30, 2021 | -4,495.00 |
| Jun 30, 2021 | -1,606.00 |
| Mar 31, 2021 | 92,395.00 |
| Dec 31, 2020 | 81,122.00 |
| Sep 30, 2020 | 59,176.00 |
| Jun 30, 2020 | 58,877.00 |
| Mar 31, 2020 | -54,981.00 |
| Dec 31, 2019 | -26,761.00 |
| Sep 30, 2019 | -25,539.00 |
| Jun 30, 2019 | -30,327.00 |
| Mar 31, 2019 | -4,548.00 |
| Dec 31, 2018 | 10,522.00 |
| Sep 30, 2018 | 31,097.00 |